Osgood-Schlatter Disease

The tibial tubercle apophysis (secondary ossification center) is biomechanically weaker than mature bone or the patellar tendon. During the adolescent growth spurt, rapid bone growth increases muscle-tendon tension while the apophysis has not yet fused. Repetitive traction from the powerful quadriceps causes microtrauma, inflammation, and sometimes fragmentation of the apophysis.

A common viva extension is "name other traction apophysites" - OSD is the prototype of a family of overuse injuries at a tendon/muscle insertion onto a secondary ossification centre (apophysis) during the growth spurt, all sharing the same biology and conservative management:

• Osgood-Schlatter - tibial tubercle (patellar tendon insertion).
• Sinding-Larsen-Johansson - inferior pole of the patella (patellar tendon origin) - same knee, one level higher.
• Sever disease - calcaneal apophysis (Achilles insertion) - the commonest cause of paediatric heel pain.
• Iselin disease - base of the 5th metatarsal (peroneus brevis insertion).
• Medial epicondyle apophysitis ("Little League elbow") - medial humeral epicondyle (common flexor-pronator/UCL traction).
• Others: iliac crest / ASIS / AIIS apophysitis (pelvic avulsion spectrum), and the olecranon apophysis in throwers/gymnasts.

The unifying principles: a growing athlete, activity-related pain at the named bony insertion, a clinical diagnosis (imaging only for atypical features/avulsion), and self-limiting with load management, stretching and time until the apophysis fuses.

Exam point: when asked, frame OSD as a traction apophysitis and name the parallel sites (SLJ, Sever, Iselin, Little League elbow) with the shared "growing athlete + insertional pain + conservative + self-limiting" rule.

Increased Q-angle (greater than 15 degrees in males, greater than 18 degrees in females) may increase lateral patellar tracking and contribute to patellofemoral symptoms. However, the relationship between Q-angle and OSD specifically is less clear. Q-angle is more relevant to patellofemoral pain syndrome.

Osgood-Schlatter is a CLINICAL diagnosis. Imaging is NOT required in typical cases. Key clinical features (point tenderness over tibial tubercle in athletic adolescent during growth spurt) are sufficient for diagnosis. Reserve imaging for atypical presentations or to exclude other pathology.

The vivas above ask "what is genu recurvatum and why does it occur?" - here is the examinable answer, which is a paediatric physeal problem distinct from any adult cause:

• What it is: a knee that hyperextends (a recurvatum deformity) - the tibia sits in extension beyond neutral.
• Why it occurs in this context: the tibial tubercle apophysis is the anterior extension of the proximal tibial physis. An injury to that anterior physis - from a tubercle avulsion fracture, from its surgical fixation across the physis in a young child, or (rarely) from severe apophyseal disruption - can cause a localised anterior growth arrest. The posterior physis keeps growing while the front does not, so the proximal tibia tilts into recurvatum (an asymmetric physeal arrest deformity).
• Who is at risk: the skeletally immature child with substantial growth remaining - which is exactly why hardware is ideally kept out of/parallel to the physis and why these children need growth monitoring after tubercle injury or surgery.
• Why OSD itself rarely causes it: ordinary OSD does not arrest the physis (Krause's natural-history series found NO premature epiphyseal arrest) - recurvatum is a complication of the avulsion/iatrogenic end of the spectrum, not of uncomplicated apophysitis.

Exam point: genu recurvatum after a tibial tubercle injury = anterior proximal-tibial physeal arrest with continued posterior growth in a skeletally immature child - prevent it by respecting the physis and monitoring growth; uncomplicated OSD does not cause it.

Parents often worry about the residual bump over the tibial tubercle. Reassure them this is part of the normal healing process - the prominence represents bone that formed during the inflammatory phase and is now incorporated into the mature tubercle. It is cosmetic only and does not affect function or sports performance.

No society publishes a formal high-level (Grade A) treatment guideline for OSD because randomised evidence is sparse. Recommendations are consensus/expert-opinion level, converging on the same message: clinical diagnosis, conservative load-managed treatment, and surgery only for the skeletally mature refractory ossicle. Injection therapies (including prolotherapy) remain investigational with low-quality evidence (Sanderson and Bryant, J Foot Ankle Res 2015, PMID 26500703).